Children With Congenital Heart Disease May Face More Behavioral Problems

Medically reviewed by Carmen Pope, Senior Medical Editor, B. Pharm. Last updated on April 28, 2026.

via HealthDay

TUESDAY, April 28, 2026 -- Children born with congenital heart disease (CHD) may have a greater risk for developing behavioral problems during preschool, according to a study published online April 22 in Frontiers in Pediatrics.

Andrew T.M. Chew, M.D., from King's College London, and colleagues compared behavioral outcomes of preschool children with and without CHD to investigate whether a cognitively stimulating home environment impacts their behavioral outcomes. The analysis included 56 preschool children (4 to 6 years of age) with CHD and 215 control participants.

The researchers found that compared with controls, children with CHD had higher levels of age-adjusted hyperactivity/impulsivity (B = −0.339), hyperactivity/inattention (B = −0.390), and peer relationship problems (B= −0.298) when controlling for gestational age at birth, sex, and neighborhood deprivation. Results survived false discovery rate correction. There were no differences between children with and without CHD for other behavioral measures assessed. The relationship between cognitively stimulating opportunities at home and selective behavioral outcomes, including hyperactivity/impulsivity, inattention, and peer problems, was significantly moderated by group. There were significant associations between more cognitively stimulating opportunities at home and more favorable behavioral outcomes in children with CHD (hyperactivity/impulsivity, B = −0.092; hyperactivity/inattention, B = −0.088; peer problems, B = −0.124) but not in controls (hyperactivity/impulsivity, B = −0.005; hyperactivity/inattention, B = −0.019; peer problems, B = −0.002).

"Clinically, these findings suggest that behavior in preschool children with CHD should be assessed regularly so that any problems can be identified and children can be supported as soon as possible," coauthor Chiara Nosarti, Ph.D., also from King's College London, said in a statement.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords